Annual Cash & Cash Equivalents
$50.87 M
+$48.39 M+1953.53%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual cash & cash equivalents is $50.87 million, with the most recent change of +$48.39 million (+1953.53%) on June 30, 2024.
- During the last 3 years, BNTC annual cash & cash equivalents has risen by +$31.10 million (+157.30%).
- BNTC annual cash & cash equivalents is now at all-time high.
Performance
BNTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$67.84 M
+$16.98 M+33.37%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly cash and cash equivalents is $67.84 million, with the most recent change of +$16.98 million (+33.37%) on September 30, 2024.
- Over the past year, BNTC quarterly cash and cash equivalents has increased by +$47.47 million (+232.98%).
- BNTC quarterly cash and cash equivalents is now at all-time high.
Performance
BNTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BNTC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1953.5% | +233.0% |
| 3 y3 years | +157.3% | +233.0% |
| 5 y5 years | +223.6% | +233.0% |
BNTC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1953.5% | at high | +2638.8% |
| 5 y | 5-year | at high | +1953.5% | at high | +2638.8% |
| alltime | all time | at high | +1953.5% | at high | +2638.8% |
Benitec Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $67.84 M(+33.4%) |
| Jun 2024 | $50.87 M(+1953.5%) | $50.87 M(+259.7%) |
| Mar 2024 | - | $14.14 M(-30.6%) |
| Dec 2023 | - | $20.37 M(-21.2%) |
| Sep 2023 | - | $25.86 M(+944.2%) |
| Jun 2023 | $2.48 M(-39.0%) | $2.48 M(-62.2%) |
| Mar 2023 | - | $6.55 M(-37.8%) |
| Dec 2022 | - | $10.54 M(-36.3%) |
| Sep 2022 | - | $16.53 M(+307.0%) |
| Jun 2022 | $4.06 M(-79.5%) | $4.06 M(-52.9%) |
| Mar 2022 | - | $8.63 M(-30.0%) |
| Dec 2021 | - | $12.33 M(-21.6%) |
| Sep 2021 | - | $15.73 M(-20.4%) |
| Jun 2021 | $19.77 M(+101.7%) | $19.77 M(+64.9%) |
| Mar 2021 | - | $11.99 M(-14.4%) |
| Dec 2020 | - | $14.01 M(+88.1%) |
| Sep 2020 | - | $7.45 M(-24.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | $9.80 M(-37.6%) | $9.80 M(-37.6%) |
| Jun 2019 | $15.72 M(+33.0%) | $15.72 M(-3.8%) |
| Dec 2018 | - | $16.33 M(+38.2%) |
| Jun 2018 | $11.82 M(-11.5%) | $11.82 M(+46.2%) |
| Mar 2018 | - | $8.08 M(+0.9%) |
| Dec 2017 | - | $8.01 M(-30.5%) |
| Sep 2017 | - | $11.53 M(-13.6%) |
| Jun 2017 | $13.35 M(-1.9%) | $13.35 M(-11.0%) |
| Mar 2017 | - | $15.01 M(+69.8%) |
| Dec 2016 | - | $8.84 M(-13.5%) |
| Sep 2016 | - | $10.22 M(-25.0%) |
| Jun 2016 | $13.61 M(-18.5%) | $13.61 M(-10.6%) |
| Mar 2016 | - | $15.22 M(-8.2%) |
| Dec 2015 | - | $16.57 M(-0.8%) |
| Jun 2015 | $16.71 M(-18.5%) | $16.71 M(-23.9%) |
| Dec 2014 | - | $21.95 M(+7.0%) |
| Jun 2014 | $20.51 M(-28.3%) | $20.51 M |
| Jun 2013 | $28.62 M | - |
FAQ
- What is Benitec Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Benitec Biopharma?
- What is Benitec Biopharma annual cash & cash equivalents year-on-year change?
- What is Benitec Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Benitec Biopharma?
- What is Benitec Biopharma quarterly cash and cash equivalents year-on-year change?
What is Benitec Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of BNTC is $50.87 M
What is the all time high annual cash & cash equivalents for Benitec Biopharma?
Benitec Biopharma all-time high annual cash & cash equivalents is $50.87 M
What is Benitec Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, BNTC annual cash & cash equivalents has changed by +$48.39 M (+1953.53%)
What is Benitec Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BNTC is $67.84 M
What is the all time high quarterly cash and cash equivalents for Benitec Biopharma?
Benitec Biopharma all-time high quarterly cash and cash equivalents is $67.84 M
What is Benitec Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, BNTC quarterly cash and cash equivalents has changed by +$47.47 M (+232.98%)